Serine/arginine-rich splicing factor 6 (SRSF6) is highly expressed in the cancer tissues of patients with metastatic tumors and is induced by TGF-β1 via suppressing SRSF6 repressing lncRNA LINC01133 [123]. Here, SRSF6 is linked to cancer.